SecBot SecBot
SECBOTREPLAY Home › Report › UTHR

UTHR · Chairperson & CEO Martine Rothblatt conducted a series of derivative…

UNITED THERAPEUTICS Corp · CLUSTER filed Mar 5, 2026 at 19:00 ET

At the news

BEARISHIMPACT 6/10

CLUSTER filed Mar 5, 2026 at 19:00 ET

Chairperson & CEO Martine Rothblatt conducted a series of derivative exercises and open-market sales over a 5-day period, realizing over $2.5 million in proceeds from selling 1,500 shares, while Director Judy Olian sold $107,088 worth of stock. The majority of transactions were non-cash derivative exercises, but the open-market sales by top executives signal material insider selling.

  • CEO Martine Rothblatt sold 1,500 shares in open-market transactions between March 12–16, 2026, for total proceeds of $1,122,078.15
  • Rothblatt also exercised derivatives for 38,000 shares (28,500 at $146.03 and 9,500 at $0), representing non-cash transactions
  • Director Judy Olian sold 200 shares for $107,088 in open-market trade
  • Total open-market selling by insiders in the cluster: $1,229,166.15

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access